MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

BriaCell Therapeutics Corp. (BCTXW)

BriaCell Therapeutics Corp. (BCTXW)

|||

Balance Sheets Overview

Current Ratio
342.05%
Quick Ratio
342.05%
Cash Ratio
81.80%
Unit: Dollar
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Amounts receivable and prepaid e...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Share capital of no par value a...
    • Warrant reserve
    • Others
Balance Sheets
2025-10-31
2025-07-31
Cash and cash equivalents
2,714,012
10,493,808
Short-term investments
7,461,960
7,372,473
Amounts receivable and prepaid expenses
1,172,435
2,060,295
Total current assets
11,348,407
19,926,576
Equity investment in bc therapeutics
554,448
524,278
Intangible assets, net
180,707
184,525
Property and equipment, net
273,980
296,819
Long term prepaid expenses
717,508
717,508
Total non-current assets
1,726,643
1,723,130
Total assets
13,075,050
21,649,706
Trade payables
2,128,915
3,283,703
Accrued expenses and other payables
1,188,858
694,285
Total current liabilities
3,317,773
3,977,988
Warrant liability
406,873
337,672
Total non-current liabilities
406,873
337,672
Share capital of no par value authorized unlimited at october 31, 2025 and july 31, 2025 issued and outstanding 1,883,906 shares at october 31, 2025 and july 31, 2025, respectively
101,739,923
101,739,923
Share-based payment reserved
10,610,826
10,316,140
Warrant reserve
17,719,026
17,719,026
Accumulated other comprehensive loss
-138,684
-138,684
Non-controlling interest
-627,558
-546,795
Accumulated deficit
-119,953,129
-111,755,564
Total shareholders equity
9,350,404
17,334,046
Total liabilities and shareholders equity
13,075,050
21,649,706
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$7,461,960 Cash and cashequivalents$2,714,012 Amounts receivable andprepaid expenses$1,172,435 Long term prepaidexpenses$717,508 Equity investment in bctherapeutics$554,448 Property and equipment,net$273,980 Intangible assets, net$180,707 Total current assets$11,348,407 Total non-currentassets$1,726,643 Total assets$13,075,050 Total liabilities andshareholders equity$13,075,050 Total shareholdersequity$9,350,404 Total currentliabilities$3,317,773 Total non-currentliabilities$406,873 Accumulated deficit-$119,953,129 Non-controlling interest-$627,558 Accumulated othercomprehensive loss-$138,684 Share capital of no parvalue authorized...$101,739,923 Trade payables$2,128,915 Accrued expenses andother payables$1,188,858 Warrant liability$406,873 Warrant reserve$17,719,026 Share-based paymentreserved$10,610,826